Nitric oxide synthase in skeletal muscle fibers of patients with type 2 diabetes

Acta Histochemica

Volumn 115, Issue 4, 2013, Pages 389-393

  Punkt, Karla ^a   Kandt, Katharina ^a   Oberbach, Andreas ^a   Adams, Volker ^a   Buchwalow, Igor ^b   Bluher, Matthias ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Institute for Hematopathology   (Germany)

Author keywords

Cytophotometry; Diabetes; Human skeletal muscle fibers; Muscle phenotype; Nitric oxide synthase

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPHOTOMETRY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME GLYCOSYLATION; ENZYME LOCALIZATION; FEMALE; GLUCOSE TOLERANCE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TISSUE DISTRIBUTION; VASTUS LATERALIS MUSCLE;

DIABETES MELLITUS, TYPE 2; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MIDDLE AGED; MUSCLE FIBERS, SKELETAL; NITRIC OXIDE SYNTHASE;

EID: 84876311358     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2012.09.014     Document Type: Article

References (23)

1. Bredt D.S. NO skeletal muscle derived relaxing factor in Duchenne muscular dystrophy. Proc Natl Acad Sci USA 1998, 95:14592-14593.
2. Buchwalow I.B., Minin E.A., Muller F.U., Lewin G., Samoilova V.E., Schmitz W., et al. Nitric oxide synthase in muscular dystrophies: a re-evaluation. Acta Neuropathol 2006, 111:579-588.
3. Buchwalow I.B., Minin E.A., Samoilova V.E., Boecker W., Wellner M., Schmitz W., et al. Compartmentalization of NO signaling cascade in skeletal muscles. Biochem Biophys Res Commun 2005, 330:615-621.
4. Committee Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2000, 23:4-19.
5. De Angelis K.L., Cestari I.A., Barp J., Dall'Ago P., Fernandes T.G., de Bittencourt P.I., et al. Oxidative stress in the latissimus dorsi muscle of diabetic rats. Brazilian J Med Biol Res 2000, 33:1363-1368.
6. De Vriese A.S., Verbeuren T.J., Van de Voorde J., Lameire N.H., Vanhoutte P.M. Endothelial dysfunction in diabetes. Br J Pharmacol 2000, 130:963-974.
7. Fritzsche K., Bluher M., Schering S., Buchwalow I.B., Kern M., Linke A., et al. Metabolic profile and nitric oxide synthase expression of skeletal muscle fibers are altered in patients with type 1 diabetes. Exp Clin Endocr Diabetes 2008, 116:606-613.
8. Gath I., Closs E.I., Godtel-Armbrust U., Schmitt S., Nakane M., Wessler I., et al. Inducible NO synthase II and neuronal NO synthase I are constitutively expressed in different structures of guinea pig skeletal muscle: implications for contractile function. FASEB J 1996, 10:1614-1620.
9. Guth L., Samaha F.J. Procedure for the histochemical demonstration of actomyosin ATPase. Exp Neurol 1970, 28:365-367.
10. Johansson B.L., Wahren J., Pernow J. C-Peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism. Am J Physiol Endocr Metab 2003, 285:E864-E870.
11. Kashyap S.R., Roman L.J., Lamont J., Masters B.S., Bajaj M., Suraamornkul S., et al. Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects. J Clin Endocr Metab 2005, 90:1100-1105.
12. Kashyap S.R., Roman L.J., Mandarino L., DeFronzo R., Bajaj M. Hypoadiponectinemia is closely associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects. Metabolic Syndr Rel Dis 2010, 8:459-463.
13. Kingwell B.A., Tran B., Cameron J.D., Jennings G.L., Dart A.M. Enhanced vasodilation to acetylcholine in athletes is associated with lower plasma cholesterol. Am J Physiol 1996, 270:H2008-H2013.
14. Kobzik L., Stringer B., Balligand J.L., Reid M.B., Stamler J.S. Endothelial type nitric oxide synthase in skeletal muscle fibers: mitochondrial relationships. Biochem Biophys Res Commun 1995, 211:375-381.
15. Lojda Z., Gutmann E. Histochemistry of some acid hydrolases in striated muscles of the rat. Histochemistry 1976, 49:337-342.
16. McCord J.M. Superoxide dismutase in aging and disease: an overview. Methods Enzymol 2002, 349:331-341.
17. Napoli C., Ignarro L.J. Nitric oxide and atherosclerosis. Nitric Oxide 2001, 5:88-97.
18. Oberbach A., Bossenz Y., Lehmann S., Niebauer J., Adams V., Paschke R., et al. Altered fiber distribution and fiber-specific glycolytic and oxidative enzyme activity in skeletal muscle of patients with type 2 diabetes. Diabetes Care 2006, 29:895-900.
19. Punkt K. Fibre types in skeletal muscles. Adv Anat Embryol Cell Biol 2002, 162:III-XV. 1-109.
20. Punkt K., Fritzsche M., Stockmar C., Hepp P., Josten C., Wellner M., et al. Nitric oxide synthase in human skeletal muscles related to defined fibre types. Histochem Cell Biol 2006, 125:567-573.
21. Punkt K., Schering S., Fritzsche M., Asmussen G., Minin E.A., Samoilova V.E., et al. Fibre-related nitric oxide synthase (NOS) in Duchenne muscular dystrophy. Acta Histochem 2007, 109:228-236.
22. Solomon T.P., Haus J.M., Li Y., Kirwan J.P. Progressive hyperglycemia across the glucose tolerance continuum in older obese adults is related to skeletal muscle capillarization and nitric oxide bioavailability. J Clin Endocr Metab 2011, 96:1377-1384.
23. Torres S.H., De Sanctis J.B., de L.B.M., Hernandez N., Finol H.J. Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients. J Endocrinol 2004, 181:419-427.